Topics

Human medicines European public assessment report (EPAR): Revestive, teduglutide, Malabsorption Syndromes, Date of authorisation: 30/08/2012, Revision: 14, Status: Authorised

09:55 EST 11 Feb 2020 | European Medicines Agency

Human medicines European public assessment report (EPAR): Revestive, teduglutide, Malabsorption Syndromes, Date of authorisation: 30/08/2012, Revision: 14, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Revestive, teduglutide, Malabsorption Syndromes, Date of authorisation: 30/08/2012, Revision: 14, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Revestive, teduglutide, Malabsorption Syndromes, Date of authorisation: 30/08/2012, Revision: 14, Status: Authorised"

Quick Search